SCHEMBL21454026

SCHEMBL21454026

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(N4c5ccccc5C5(c6ccccc64)c4ccccc4N(c4ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc4)c4ccccc45)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
ADAMTS5 Q9UNA0 1/20 0.38
PDE6D O43924 1/20 0.38
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
POLB P06746 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19565810 0.94 PDE6D (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL29712520 0.94 PDE6D (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL20347848 0.93 PDE6D (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL20347853 0.93 L3MBTL1 (0.35) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL20229427 0.92 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21454024 0.90 ADAMTS5 (0.39) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL29892647 0.90 ADAMTS5 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL20347851 0.90 ADAMTS5 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL20347845 0.89 ADAMTS5 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21702809 0.89 ADAMTS5 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200251663-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-06 US disclosed
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLCO2A1, SLCO1A2 L3MBTL1 2377/4885MEN1 1688/4885KMT2A 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.